David A. Siegel Cumberland Pharmaceuticals Inc Transaction History

Two Sigma Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.68 - $2.24 $672 - $896	-400 Reduced 1.71%	23,000 $38,000
Q4 2023 Feb 14, 2024	SELL	$1.6 - $2.14 $320 - $428	-200 Reduced 0.85%	23,400 $41,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.01 $147 - $200	-100 Reduced 0.42%	23,600 $34,000
Q1 2023 May 15, 2023	SELL	$1.92 - $2.75 $1,536 - $2,200	-800 Reduced 3.27%	23,700 $46,000
Q4 2022 Feb 14, 2023	SELL	$2.11 - $2.6 $422 - $520	-200 Reduced 0.81%	24,500 $55,000
Q3 2022 Nov 14, 2022	SELL	$2.06 - $2.63 $20,377 - $26,015	-9,892 Reduced 28.6%	24,700 $60,000
Q2 2022 Aug 15, 2022	SELL	$1.93 - $3.03 $133,606 - $209,754	-69,226 Reduced 66.68%	34,592 $72,000
Q1 2022 May 16, 2022	BUY	$2.56 - $4.98 $172,334 - $335,243	67,318 Added 184.43%	103,818 $293,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $6.94 $80,300 - $253,310	36,500 New	36,500 $170,000

24.2K

200

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $18.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.